UCB - Current Assets



UCB reported EUR4.79B in Current Assets for its fiscal semester ending in December of 2024.


Current Assets Change Date
Alcon AG USD 6.31B 239M Jun/2025
Almirall EUR 714.05M 50.55M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
argenx SE 5.83B 946.64M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Orion EUR 1.01B 76.5M Jun/2025
Recordati EUR 1.57B 3.62M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
UCB EUR 4.79B 1.47B Dec/2024
Unibail Rodamco EUR 7.12B 550.2M Dec/2024